Labang, Ressa P.
HRN: 25-04-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CEFUROXIME 500MG (TAB)
06/30/2026
07/07/2026
PO
500 Mg
BID
Sp 1 LTCS
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: